CURI(CURI)
CURI
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $79M | $89M | $98M |
| Low | $79M | $89M | $96M |
| High | $80M | $89M | $100M |
| EBITDA Avg | $-7M | $-8M | $-9M |
| Low | $-7M | $-8M | $-9M |
| High | $-7M | $-8M | $-9M |
| EBIT Avg | $-37M | $-42M | $-46M |
| Low | $-38M | $-42M | $-47M |
| High | $-37M | $-42M | $-45M |
| Net Income Avg | $12M | $14M | $24M |
| Low | $3M | $11M | $24M |
| High | $19M | $18M | $25M |
| EPS Avg | $0.20 | $0.25 | $0.42 |
| Low | $0.05 | $0.19 | $0.41 |
| High | $0.33 | $0.31 | $0.43 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $20M | $21M | $19M | $24M | $22M | $23M |
| Low | $20M | $21M | $18M | $24M | $22M | $22M |
| High | $20M | $21M | $19M | $25M | $23M | $23M |
| EBITDA Avg | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M |
| Low | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M |
| High | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M |
| EBIT Avg | $-9M | $-10M | $-9M | $-11M | $-11M | $-11M |
| Low | $-9M | $-10M | $-9M | $-12M | $-11M | $-11M |
| High | $-9M | $-10M | $-9M | $-11M | $-10M | $-10M |
| Net Income Avg | $2M | $3M | $2M | $6M | $3M | $3M |
| Low | $909,105 | $3M | $2M | $6M | $3M | $3M |
| High | $3M | $3M | $2M | $6M | $4M | $4M |
| EPS Avg | $0.03 | $0.04 | $0.04 | $0.10 | $0.06 | $0.06 |
| Low | $0.01 | $0.04 | $0.04 | $0.10 | $0.05 | $0.05 |
| High | $0.04 | $0.05 | $0.04 | $0.11 | $0.06 | $0.06 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |